Clinical trials
Phase 1 Hypertension, Pulmonary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2009 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 6 |
| Recruiting | 4 |
| Unknown status | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Gladwin, Mark, MD | 2 |
| United Therapeutics | 2 |
| 35Pharma Inc | 1 |
| Aadi Bioscience, Inc. | 1 |
| Aires Pharmaceuticals, Inc. | 1 |
| Duke University | 1 |
| Janssen Research & Development, LLC | 1 |
| Mario Castro, MD, MPH | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypertension, Pulmonary | 28 |
| Anemia, Sickle Cell | 4 |
| Pulmonary Arterial Hypertension | 4 |
| Acute Chest Syndrome | 2 |
| Bronchopulmonary Dysplasia | 2 |
| Disease | 2 |
| Heart Failure | 2 |
| Premature Birth | 2 |
| Pulmonary Disease, Chronic Obstructive | 2 |
| Respiratory Distress Syndrome | 2 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.